Hodgkin & Non-Hodgkin lymphomas

Proton therapy to treat Hodgkin & Non-Hodgkin lymphomas

Lymphoma patients treated with proton therapy are being followed for longer term data and the number of clinical outcome studies is increasing. Protons are the best to achieve organ specific dose reduction for heart, lung, esophagus, breast and other structures. Reported data has shown encouraging disease control and an expected reduction in long-term adverse effects, given the minimized target volume and significant dose reduction to normal tissue.

cellule
White paper

Treating Hodgkin & Non-Hodgkin lymphomas with proton therapy

Read our white paper - PDF

Download access

Please fill in the form to download the document.

First name*
Last name*
Professional Email*
Job title*
Country*
Company*
Best
describes me*
IBA uses and stores cookies and other tracking technologies as specified in the IBA's Cookies Policy to improve your browsing experience on our website, and to understand where our visitors are coming from.

Your information will be collected, stored, and used according to IBA’s Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Growing interest and implementation of proton therapy for Hodgkin and Non-Hodgkin lymphomas

The expert's perspective.

According to Dr. Bradfort S. Hoppe: “Using this modality potentially improves the therapeutic ratio. In Hodgkin lymphoma patients, proton therapy can help minimize toxicity and maximize the cure rate. In addition, many lymphomas are found in the mediastinum, adjacent to the lung, heart and breast tissue, which are all extremely sensitive to chemotherapy and radiation and can lead to second cancers and cardiac complications. Because of the fear of these long-term radiation toxicities, medical oncologists often won’t send their patients for radiation. However, proton therapy can potentially reduce these late toxicities.”

oval

Your proton therapy community

Campus is the most knowledgeable proton therapy community in the world. With Campus, physicians, medical physicists, dosimetrists, therapists, managers and industry partners will have the tools to share knowledge, and find the information they need at every stage of their proton therapy journey.

view campus

Frequently asked questions

How can I know more about the indications of proton therapy?

In this website, we provide you with extensive literature and documents about PT research and indications. In particular, we've compiled a series of in-depth white papers exploring the various types of cancers for which proton therapy could be a viable first-choice option.

 
Know more about proton therapy's efficiency

Proton therapy is indicated in an increasing number of types of tumors. To know more about proton therapy therapy's efficiency and indications, consult our pages on how to start a treatment and the different types of cancers in which oncologist choose proton therapy as a first-choice treatment.

 
What types of cancers does proton therapy treat best?

Proton Therapy is indicated in an increasing number of types of tumors. As it minimizes...

 

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Cookies policies